Clifton O. Brock

Dr. Clifton O. Brock


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2020 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
LTLisanne Tollenaar
Lisanne Tollenaar
FSF. Slaghekke
F. Slaghekke
Liesbeth LewiLiesbeth Lewi
Liesbeth Lewi
YVYves Ville
Yves Ville
MLM. Lanna
M. Lanna
JCJ. A. Copel
J. A. Copel
Objective: To investigate the antenatal management and outcome in a large international cohort of monochorionic twin pregnancies with spontaneous or post‐laser twin anemia–polycythemia sequence (TAPS).Methods: This study analyzed data of monochorionic twin pregnancies diagnosed antenatally with spontaneous or post‐laser TAPS in 17 fetal therapy centers, recorded in the TAPS Registry between 2014 and 2019. Antenatal diagnosis of TAPS was based on fetal middle cerebral artery peak systolic velocity > 1.5 multiples of the median (MoM) in the TAPS donor and < 1.0 MoM in the TAPS recipient. The following antenatal management groups were defined: expectant management, delivery within 7 days after diagnosis, intrauterine transfusion (IUT) (with or without partial exchange transfusion (PET)), laser surgery and selective feticide. Cases were assigned to the management groups based on the first treatment that was received after diagnosis of TAPS. The primary outcomes were perinatal mortality and severe neonatal morbidity. The secondary outcome was diagnosis‐to‐birth interval.Results: In total, 370 monochorionic twin pregnancies were diagnosed antenatally with TAPS during the study period and included in the study. Of these, 31% (n = 113) were managed expectantly, 30% (n = 110) with laser surgery, 19% (n = 70) with IUT (± PET), 12% (n = 43) with delivery, 8% (n = 30) with selective feticide and 1% (n = 4) underwent termination of pregnancy. Perinatal mortality occurred in 17% (39/225) of pregnancies in the expectant‐management group, 18% (38/215) in the laser group, 18% (25/140) in the IUT (± PET) group, 10% (9/86) in the delivery group and in 7% (2/30) of the cotwins in the selective‐feticide group. The incidence of severe neonatal morbidity was 49% (41/84) in the delivery group, 46% (56/122) in the IUT (± PET) group, 31% (60/193) in the expectant‐management group, 31% (57/182) in the laser‐surgery group and 25% (7/28) in the selective‐feticide group. Median diagnosis‐to‐birth interval was longest after selective feticide (10.5 (interquartile range (IQR), 4.2–14.9) weeks), followed by laser surgery (9.7 (IQR, 6.6–12.7) weeks), expectant management (7.8 (IQR, 3.8–14.4) weeks), IUT (± PET) (4.0 (IQR, 2.0–6.9) weeks) and delivery (0.3 (IQR, 0.0–0.5) weeks). Treatment choice for TAPS varied greatly within and between the 17 fetal therapy centers.Conclusions: Antenatal treatment for TAPS differs considerably amongst fetal therapy centers. Perinatal mortality and morbidity were high in all management groups. Prolongation of pregnancy was best achieved by expectant management, treatment by laser surgery or selective feticide. © 2020 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of the International Society of Ultrasound in Obstetrics and Gynecology.

15 June 2021 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Closed access
PDF file
CBC. Buskmiller
C. Buskmiller
EBEric Bergh
Eric Bergh
CBClifton O. Brock
Clifton O. Brock
JMJena L Miller
Jena L Miller
ABAhmet Alexander Baschat
Ahmet Alexander Baschat
Ramesha PapannaRamesha Papanna
Ramesha Papanna

10 January 2022 in American Journal of Obstetrics & Gynecology MFM
Verified
Journal Article
Open access
CBClifton O. Brock
Clifton O. Brock
EBEric P. Bergh
Eric P. Bergh
AJAnthony Johnson
Anthony Johnson
RRRodrigo Ruano
Rodrigo Ruano
EHEdgar Hernandez-Andrade
Edgar Hernandez-Andrade
Ramesha PapannaRamesha Papanna
Ramesha Papanna
A consensus definition of selective fetal growth restriction in monochorionic diamniotic twins was recently proposed following a Delphi procedure involving an international panel of experts. The new definition augments the traditional definition with additional sonographic criteria. We sought to determine whether the augmentations of the "Delphi definition" identified additional morbidity and mortality compared with a traditional definition. Furthermore, we sought to determine the benefit of each definition in identifying pathologic growth restriction relative to uncomplicated monochorionic diamniotic twins. This was a retrospective analysis of unselected monochorionic diamniotic twins that underwent fortnightly ultrasound surveillance at a single center between 2011 and 2020. Patients with concomitant twin-to-twin transfusion syndrome, twin anemia polycythemia sequence, or twin reversed arterial perfusion sequence at the time of diagnosis of selective fetal growth restriction were excluded. The diagnosis of selective fetal growth restriction using the Delphi definition required either an estimated fetal weight of <3rd percentile or presence of 2 of 4 observations in the smaller twin: (1) estimated fetal weight of 25% compared with the larger twin, (3) abdominal circumference of 95th percentile. Diagnosis using the traditional definition required an estimated fetal weight of 25%. To determine the efficacy of the augmentations in the Delphi definition, 3 groups were compared: group I, uncomplicated monochorionic diamniotic twins; group II, twins with selective fetal growth restriction using the traditional definition (and therefore the Delphi definition); and group III, twins with selective fetal growth restriction solely using the Delphi definition. Demographic characteristics, subsequent development of twin-to-twin transfusion syndrome or twin anemia polycythemia sequence, pregnancy outcomes, and neonatal outcomes were compared. There were 325 patients with monochorionic diamniotic twins that met inclusion criteria. Of these, 213 (66%; group I) were uncomplicated, 37 (11%; group II) met the traditional definition for selective fetal growth restriction, and 112 (35%) met the Delphi definition for selective fetal growth restriction with 75 (67%) meeting solely the Delphi definition (group III). Demographic characteristics were similar between groups. Patients in group II delivered earlier than uncomplicated twins (32.1 vs 35.7 weeks of gestation; P<.01) and patients in group III (32.1 vs 35.6 weeks of gestation; P<.01). Furthermore, they were more likely to have critical umbilical artery Doppler abnormalities (38% vs 4%; P<.01) and be delivered for deteriorating fetal status (30% vs 5%; P<.01) than those in group III. Overall, survival was lower in group II than groups I and III (89% vs 96% and 100%, respectively; P=.04). Moreover, composite neonatal morbidity and mortality were greater in group II (30%) than either group I (6%; P<.01) or group III (9%; P<.01). The rates of composite neonatal morbidity and mortality were similar between groups I and III (P=.28). The addition of abdominal circumference and umbilical artery pulsatility index thresholds and isolated estimated fetal weight of <3%, as proposed by the Delphi definition, increased the diagnosis of selective fetal growth restriction; however, there was no added benefit in the identification of growth discordant pregnancies at risk of adverse outcomes. Prospective analysis of monochorionic diamniotic twins is required to contextualize these findings.

8 October 2020 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Closed access
PDF file
RDR. Donepudi
R. Donepudi
CBClifton O. Brock
Clifton O. Brock
SSS. Schulte
S. Schulte
EBE. Bundock
E. Bundock
SFS. Fletcher
S. Fletcher
KTK. Tsao
K. Tsao

11 August 2020 in Prenatal Diagnosis
Verified
Journal Article
Closed access
PDF file
CBClifton O. Brock
Clifton O. Brock
BSBaha M. Sibai
Baha M. Sibai
ESEleazar E. Soto
Eleazar E. Soto
KMKenneth J. Moise
Kenneth J. Moise
AJAnthony Johnson
Anthony Johnson
Ramesha PapannaRamesha Papanna
Ramesha Papanna

7 December 2024 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Closed access
CBClifton O. Brock
Clifton O. Brock
SBS. Backley
S. Backley
SSS. Snowise
S. Snowise
EBEric Bergh
Eric Bergh
AJA. Johnson
A. Johnson
Ramesha PapannaRamesha Papanna
Ramesha Papanna